Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Higher androgen levels are linked to more severe hair growth in hirsute women.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Finasteride may improve prostate cancer treatment outcomes.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Male pattern baldness involves hormones and cell signals affecting hair growth.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.